Abstract
Epidemiologic evidence regarding the association between carbohydrate intake, glycemic load and glycemic index and risk of ovarian cancer has been mixed. Little is known about their impact on ovarian cancer risk in African-American women. Associations between carbohydrate quantity and quality and ovarian cancer risk were investigated among 406 cases and 609 controls using data from the African American Cancer Epidemiology Study (AACES). AACES is an ongoing population-based case-control study of ovarian cancer in African Americans in the US. Cases were identified through rapid case ascertainment and age- and site-matched controls were identified by random-digit-dialing. Dietary information over the year preceding diagnosis or the reference date was obtained using a food frequency questionnaire. Multivariable logistic regression models were used to estimate odds ratios (OR) and 95% confidence intervals (CI) adjusted for covariates. The ORs comparing the highest quartile of total carbohydrate intake and total sugars intake versus the lowest quartile were 1.57 (95% CI 1.08, 2.28; p-trend=0.03) and 1.61 (95% CI 1.12, 2.30; p-trend<0.01) respectively. A suggestion of an inverse association was found for fiber intake. Higher glycemic load was positively associated with the risk of ovarian cancer (OR 1.18 for each 10 units/1,000 kcal; 95% CI 1.04, 1.33). No associations were observed for starch or glycemic index. Our findings suggest that high intake of total sugars and glycemic load are associated with greater risk of ovarian cancer in African-American women.
Keywords: African American, Carbohydrate, Glycemic load, Ovarian cancer, Epidemiology
Introduction
Ovarian cancer is the leading cause of death from gynecologic cancers in developed counties including the US(1, 2), of which nearly 90% are epithelial ovarian carcinomas(3). Approximately 10% of cases are thought to arise from inherited germline mutations while the rest are thought to be sporadic(3). Because currently there is no reliable screening available for ovarian cancer, most cases are diagnosed at an advanced stage, with a poor prognosis(4). Moreover, compared to European Americans, African-American women tend to have a worse 5-year survival rate(5), highlighting a critical need for identifying modifiable preventive factors. However, there is a scarcity of epidemiological studies in this area for African-American women.
While there are few established modifiable risk factors for ovarian cancer, the role of diet has been proposed. Carbohydrates in particular have been a focus of research(6), as long-term consumption of high levels of carbohydrate, especially sugars, could plausibly contribute to ovarian carcinogenesis(7, 8). The majority of epidemiologic studies evaluating associations between intakes of carbohydrate(9-15), total sugars and added sugars(13, 15-19), and fiber(9-14, 20, 21) with ovarian cancer risk have been conducted in European or European-American populations, with mixed results. Inconsistencies in findings have been attributed to the different type, amount, and rate of digestion of carbohydrates(13). These factors may lead to varied blood glucose and postprandial insulin responses, which have been suggested to play critical roles in ovarian tumor development(13). Therefore, it is necessary to evaluate the impact of both the quality and the quantity of carbohydrate intake on ovarian cancer risk.
Glycemic index (GI) is a quality measure of carbohydrates, while glycemic load (GL) reflects both the average quality and quantity of carbohydrates. GI is a numerical index that is defined as the incremental area under the blood glucose response curve after a 50g carbohydrate of a test food relative to an equivalent carbohydrate portion of bread or glucose(22). Through combining the food's GI value and the carbohydrate content of the food's usual serving size, GLs reflect the overall effects of a food on postprandial blood glucose concentration(23). Few studies have evaluated the relation between GL, GI, and ovarian cancer risk, and the evidence is mixed(13, 15, 18, 24, 25). In three of these studies, positive associations were observed for GL only or both GI and GL(13, 15, 25), and were stronger in postmenopausal women(15, 25), or overweight and obese women(13). Two others found a null relation(18) or an inverse association for GI(24).
Compared to European Americans, African Americans have similar total carbohydrate intake, but tend to have lower fiber consumption and higher intake of total sugars and added sugars(26-28). Fiber intake has been hypothesized to be beneficial for ovarian cancer prevention while sugars intake is suggested to play the opposite role(16, 20). Furthermore, there are important differences in the physiology of glucose homeostasis between African Americans and European Americans, with higher insulin secretion and more insulin resistance in African Americans(29, 30). Therefore, our study aimed to examine the associations between types of carbohydrate intake, GL and GI with ovarian cancer risk in African-American women. We specifically examined whether associations may be stronger in postmenopausal or overweight/obese women based on previous findings(13, 15, 25), and assessed if there might be greater associations among diabetics since they may suffer from long-term higher insulin response to carbohydrate intake(8). As some studies have suggested differences in ovarian cancer risk factors by histologic subtypes(31, 32), we also proposed to examine these associations by ovarian cancer subtypes serous vs. non-serous. To our knowledge, this is the first study that examined the association between carbohydrate quality and quantity and ovarian cancer risk in African Americans.
Materials and methods
Study population
The African American Cancer Epidemiology Study (AACES) has been described in detail elsewhere(33). In brief, AACES is an ongoing population-based case-control study of ovarian cancer in African American women in 11 sites in the US (Alabama, Georgia, Illinois, Louisiana, Michigan, North Carolina, New Jersey, Ohio, South Carolina, Tennessee, and Texas). Cases were identified by rapid case ascertainment utilizing state cancer registries, SEER (Surveillance, Epidemiology, and End Results) registries or hospitals' gynecologic oncology departments. Eligible cases include all self-identified African-American women aged between 20 to 79 years, with newly diagnosed, histologically confirmed invasive epithelial ovarian cancer. Controls who self-identified as African American were selected using random-digit dialing and were matched to cases by 5-year age groups and state of residence. Women who had a previous history of ovarian cancer or a bilateral oophorectomy were ineligible controls. Only women able to complete an interview in English were eligible to participate. Among those who could be contacted, 66.5% of potential cases and 72% of potential controls agreed to participate in the main telephone interview(33). The study was approved by the Institutional Review Boards at all study sites.
We used data from AACES participants recruited from December 2010 through December 2014, which included 495 cases and 711 controls. Among them, 421 cases (85%) and 635 controls (89%) completed the food frequency questionnaire (FFQ) for dietary assessment. We compared characteristics of women completing and not completing the FFQ and found no difference with respect to age, education, region, body mass index (BMI), and smoking (results not shown). Participants were excluded from the analysis if they reported an extreme energy intake defined as greater than twice the interquartile range of log energy intake (case, N = 1; control, N = 3) or if they were missing important covariates (case: N = 14; control: N = 23), such as tubal ligation and family history of ovarian/breast cancer. The final analytical sample comprised 406 cases and 609 controls.
Data collection
Upon signing informed consent, participants completed a computer-assisted telephone interview. The questionnaire includes detailed questions on demographic information, personal and family history of cancer, reproductive history, medication use, lifestyle characteristics, and other factors of particular relevance to African-American women such as perceived discrimination, access to health care, and cultural beliefs.
Dietary intake was assessed using a self-administered Block 2005 FFQ, which included questions on frequency and portion size on 110 food items. The FFQ was mailed to participants with portion size pictures to facilitate recall. Participants were asked to estimate their usual consumption of each of these food items during the year before their reference date. Nutrient intakes were derived from the FFQ through the Block Dietary Data Systems based on the USDA Food and Nutrient Database for Dietary Studies, version 1.0. The validity of the Block food frequency questionnaire has been evaluated(34, 35). The correlations between estimates from the questionnaire and 2-day food records were >0.50 for most nutrients. In particular, the correlation of energy-adjusted carbohydrate intake was 0.60 and 0.61 respectively for women below or above age 65(35). Total carbohydrate values consist of total sugars (including added sugars), starch and fiber intakes.
The GI and GL values for food items in our study were based on the published international tables of values,(36) or from direct testing of food items at the University of North Carolina Nutrition Obesity Research Center, using glucose as the reference. The GL value of each food was calculated by multiplying the non-fiber carbohydrate contained in a specified serving size of the food by the GI value of that food, divided by 100. The daily GL value of each individual was the sum of all foods after multiplying the GL of each food by its frequency of consumption and portion size. An individual's daily GI value was determined by dividing the daily GL by the total amount of non-fiber carbohydrate consumed. Top food sources that contribute to carbohydrates, sugars, or GL in this sample are provided in Supplemental Table 1.
Statistical analysis
Distributions of demographic and major risk factors for ovarian cancer, such as parity and tubal ligation, were compared between cases and controls using chi-square tests. Student's t-tests were used to compare the mean nutrient intakes by cases and controls.
Dietary variables under investigation- total carbohydrate, total sugars, added sugars, starch, fiber and GL, except GI, were adjusted for energy intake using the multivariate nutrient density approach(37). Dietary variables were then categorized into quartiles based on the distributions among controls. Unconditional logistic regression models were used to calculate odds ratios (OR) and 95% confidence intervals (CI) for ovarian cancer risk by levels of energy-adjusted dietary intake. Linear trends were tested by modeling the median value of each quartile as a continuous variable. Dietary variables were also evaluated as a continuous increment based on the difference between the 75th and 25th percentile of the controls' distribution, rounded to one significant digit.
The first model adjusted for age, geographic region (south- and mid-Atlantic, south central, midwest), education (high school or less, some post-high school training, college or graduate degree), and total energy intake(38). Additional covariates selected for model 2 included risk factors for ovarian cancer that changed the effect estimate of each corresponding dietary variable by >10%: parity (0, 1-2, >2), oral contraceptive use (never, <60 mo, ≥60 mo), menopause status (pre-, post-menopause), tubal ligation (no, yes), first-degree family history of breast/ovarian cancer (no, yes). The second model additionally adjusted for vegetable consumption (servings, continuous) or alcohol consumption (drink-equivalent, continuous) when evaluating added sugars or fiber respectively. Since vegetable intake is an important source of fiber and affects GL and GI values, we did not adjust for vegetable consumption when evaluating their associations with ovarian cancer to avoid over-adjustment. Other potential confounders considered were age at menarche (<12, 12-13, >13), hormone therapy use (never, ever), and smoking (never, ever), but were not included in the final model since they did not change the effect estimate by 10%.
Further analyses were conducted adjusting for BMI and diabetes, both of which may be either confounders or mediators in the causal pathway between carbohydrate intake and ovarian cancer. We also considered possible confounding effects by total sugars and added sugars when evaluating fiber intake; and saturated fat and total fat intake as potential covariates for any of the associations under study.
We examined if the associations were modified by menopausal status, obesity, and diabetes by testing statistical interactions using product terms with the continuous variable of dietary intake. We also examined if the associations were different by histologic subtypes of ovarian cancer. Since smoking may be related to mucinous tumors(39), we further adjusted for smoking when examining the associations by histological subtypes. A p-value<0.1 was defined as statistical significance for interaction, while p<0.05 was used for main effects. All statistical analyses mentioned above were performed using STATA (version 11.2; STATA Corp LP). We had excellent power for main analyses evaluating carbohydrate intake, GL, GI and ovarian cancer risk. As assessed by Epi Info (version 7.1.5), we could detect an OR of 1.49 using quartile exposures based on a power of 80% and two-sided 95% CI.
Results
Compared to controls, cases were slightly older (cases mean 57.5 y vs. controls 54.5 y; p-value: 0.01), less likely to reside in the Midwest, to have children, to have used oral contraceptives, or have had a tubal ligation (Table 1). Cases were more likely to have a family history of breast/ovarian cancer. Cases were similar to controls in total energy intake and energy-adjusted total and saturated fat intake. They had statistically significant higher intakes of carbohydrate, total sugars, fructose and added sugars, higher glycemic load, and lower protein intake and alcohol consumption, although the magnitude of difference was very small for carbohydrate or protein intake comparing cases and controls (Table 2).
Table 1. Descriptive characteristics of African American women with and without ovarian cancer, AACES 2010-14.
| Cases (n=406) | Controls (n=609) | ||||
|---|---|---|---|---|---|
|
|
|||||
| Variables | n | % | n | % | P* |
| Age | |||||
| <50 | 88 | 21.7 | 172 | 28.2 | 0.01 |
| 50-59 | 146 | 36.0 | 230 | 37.8 | |
| ≥60 | 172 | 42.4 | 207 | 34.0 | |
| Education | |||||
| High school or less | 180 | 44.3 | 224 | 36.8 | 0.06 |
| Some post-high school training | 131 | 32.3 | 222 | 36.5 | |
| College or graduate degree | 95 | 23.4 | 163 | 26.8 | |
| Region† | |||||
| South- and mid-Atlantic | 228 | 56.2 | 321 | 52.7 | 0.02 |
| South central | 109 | 26.9 | 141 | 23.2 | |
| Midwest | 69 | 17.0 | 147 | 24.1 | |
| Parity | |||||
| 0 | 79 | 19.5 | 80 | 13.1 | 0.02 |
| 1-2 | 177 | 43.6 | 273 | 44.8 | |
| >2 | 150 | 37.0 | 256 | 42.0 | |
| Oral contraceptive use | |||||
| Never | 116 | 28.6 | 118 | 19.4 | <0.01 |
| <60 mo | 163 | 40.2 | 275 | 45.2 | |
| ≥60 mo | 127 | 31.3 | 216 | 35.5 | |
| Use of hormone replacement therapy among postmenopausal women | |||||
| Never | 219 | 74.5 | 321 | 76.8 | 0.48 |
| Ever | 75 | 25.5 | 97 | 23.2 | |
| Age at menarche | |||||
| <12 | 90 | 22.2 | 165 | 27.1 | 0.21 |
| 12-13 | 212 | 52.2 | 300 | 49.3 | |
| >13 | 104 | 25.6 | 144 | 23.7 | |
| Menopause status | |||||
| Premenopausal | 109 | 26.9 | 189 | 31.0 | 0.15 |
| Postmenopausal | 297 | 73.2 | 420 | 69.0 | |
| Tubal Ligation | |||||
| No | 271 | 66.8 | 364 | 59.8 | 0.02 |
| Yes | 135 | 33.3 | 245 | 40.2 | |
| Family history of breast/ovarian cancer (first-degree relative) | |||||
| No | 297 | 73.2 | 494 | 81.1 | <0.01 |
| Yes | 109 | 26.9 | 115 | 18.9 | |
| Diabetes | |||||
| No | 318 | 78.3 | 468 | 76.9 | 0.58 |
| Yes | 88 | 21.7 | 141 | 23.2 | |
| Body mass index 1y before (kg/m2)‡ | |||||
| <25 | 54 | 13.3 | 108 | 17.7 | 0.17 |
| 25-<30 | 106 | 26.1 | 151 | 24.8 | |
| ≥30 | 246 | 60.6 | 350 | 57.5 | |
| Smoking | |||||
| Never | 231 | 56.9 | 349 | 57.3 | 0.90 |
| Current/former | 175 | 43.1 | 260 | 42.7 | |
Chi-square tests.
South- and mid-Atlantic includes GA, NC, NJ, SC; South central includes AL, LA, TN, TX; and Midwest includes IL, MI, OH.
1 year before diagnosis (cases)/interview (controls).
Table 2. Energy-adjusted dietary factors of African American women with and without ovarian cancer, AACES 2010-14*.
| Cases n=406 | Controls n=609 | ||||
|---|---|---|---|---|---|
|
|
|||||
| Daily nutrient intake | Mean | SD | Mean | SD | P† |
| Total energy intake, kcal | 1795.9 | 1220.8 | 1739.0 | 1101.7 | 0.44 |
| Total carbohydrate, g/1,000 kcal | 122.8 | 19.6 | 119.6 | 20.2 | 0.01 |
| Total sugars, g/1,000 kcal | 65.4 | 22.2 | 61.5 | 20.6 | 0.005 |
| Fructose, g/1,000 kcal | 17.2 | 8.8 | 16.0 | 8.2 | 0.03 |
| Sucrose, g/1,000 kcal | 23.0 | 11.4 | 22.1 | 11.8 | 0.23 |
| Added sugars, tsp/1,000 kcal | 9.0 | 4.5 | 8.5 | 4.3 | 0.04 |
| Starch, g/1,000 kcal | 48.5 | 10.3 | 48.9 | 10.7 | 0.55 |
| Fiber, g/1,000 kcal | 8.9 | 3.6 | 9.1 | 3.9 | 0.31 |
| Glycemic load, units/1,000 kcal | 59.4 | 10.3 | 57.6 | 11.3 | 0.01 |
| Glycemic index, units | 52.2 | 3.7 | 52.1 | 4.0 | 0.60 |
| Total fat, g/1,000 kcal | 41.5 | 6.5 | 41.7 | 6.7 | 0.67 |
| Saturated fat, g/1,000 kcal | 12.3 | 2.5 | 12.3 | 2.5 | 0.86 |
| Protein, g/1,000 kcal | 37.0 | 7.7 | 37.9 | 8.2 | 0.05 |
| Alcohol, drink-equivalent‡ | 0.30 | 0.07 | 0.47 | 0.05 | 0.05 |
SD, standard deviation. tsp, teaspoon.
Glycemic index and alcohol intake is not further energy-adjusted.
Student's t-test
One drink equivalent is defined as 12 fl oz of beer, 5 fl oz of wine, or 1½ fl oz of distilled spirits.
As shown in Table 3, total carbohydrate intake was strongly positively associated with ovarian cancer risk. The multivariable-adjusted OR comparing the highest versus the lowest quartile of total carbohydrate intake was 1.57 (95% CI, 1.08-2.28; p-trend=0.03). In continuous analyses, we estimated a 32% increase in OR (95% CI, 1.09-1.61) per 30 g/1,000 kcal of carbohydrate consumption. The positive association between carbohydrate intake and ovarian cancer risk seemed to be attributable to total sugars intake, with an OR of 1.61 (95% CI, 1.12-2.30; p-trend<0.01) for those in the highest quartile compared to the lowest. Each additional 20g/1,000 kcal per day of sugars intake was associated with a 22% increased OR (95% CI, 1.08-1.37). For a 2,000-kcal diet, that increment represents approximately a can of soda or one cup of ice-cream. When further evaluating types of sugars, we observed that fructose intake was positively associated with the risk of ovarian cancer (OR, 1.23 for each 10g/1,000kcal; 95% CI, 1.05-1.43). Added sugars intake was positively associated with ovarian cancer risk but was not statistically significant. We did not find an association between starch intake and ovarian cancer risk. There was a suggestion of decreased risk for higher total fiber intake but the risk estimate was only significant for the third quartile compared to the lowest. A post hoc analysis which evaluated fiber from various sources (from vegetable and fruit; from beans; from grains) as either quartiles or continuous variable did not find any association, except a marginally significant 12% decrease in the OR (95% CI, 0.74-0.99) per 3 g/1,000 kcal of fiber from vegetable and fruit sources (data not shown).
Table 3. Association between daily dietary carbohydrate intake and ovarian cancer risk in AACES 2010-14.
| Cases N=406 | Controls N=609 | Model 1* | Model 2† | |||||
|---|---|---|---|---|---|---|---|---|
|
|
||||||||
| n | % | n | % | OR | 95% CI | OR | 95% CI | |
| Total carbohydrate, g/1,000kcal | ||||||||
| Q1 (≤106.9) | 83 | 20.4 | 153 | 25.1 | 1.00 | Ref | 1.00 | Ref |
| Q2 (107.0-120.1) | 105 | 25.9 | 153 | 25.1 | 1.31 | 0.90, 1.90 | 1.32 | 0.90, 1.92 |
| Q3 (120.2-133.1) | 97 | 23.9 | 152 | 25.0 | 1.18 | 0.81, 1.73 | 1.17 | 0.80, 1.72 |
| Q4 (≥133.2) | 121 | 29.8 | 151 | 24.8 | 1.58 | 1.10, 2.28 | 1.57 | 1.08, 2.28 |
| Ptrend | 0.03 | 0.03 | ||||||
| Per 30 g/1,000 kcal‡ | 1.33 | 1.09, 1.61 | 1.32 | 1.09, 1.61 | ||||
| Total sugars, g/1,000kcal | ||||||||
| Q1 (≤ 48.2) | 92 | 22.7 | 153 | 25.1 | 1.00 | Ref | 1.00 | Ref |
| Q2 (48.3-60.9) | 96 | 23.7 | 152 | 25.0 | 1.04 | 0.72, 1.51 | 1.03 | 0.70, 1.50 |
| Q3 (61.0-72.7) | 81 | 20.0 | 152 | 25.0 | 0.91 | 0.62, 1.33 | 0.90 | 0.61, 1.33 |
| Q4 (≥72.8) | 137 | 33.7 | 152 | 25.0 | 1.57 | 1.11, 2.24 | 1.61 | 1.12, 2.30 |
| Ptrend | 0.01 | <0.01 | ||||||
| Per 20 g/1,000 kcal ‡ | 1.21 | 1.08, 1.37 | 1.22 | 1.08, 1.37 | ||||
| Fructose | ||||||||
| Q1 (≤10.1) | 89 | 21.9 | 153 | 25.1 | 1.00 | Ref | 1.00 | Ref |
| Q2 (10.2-14.8) | 98 | 24.1 | 153 | 25.1 | 1.14 | 0.79, 1.65 | 1.10 | 0.76, 1.61 |
| Q3 (14.9-20.0) | 102 | 25.1 | 151 | 24.8 | 1.20 | 0.83, 1.74 | 1.16 | 0.79, 1.68 |
| Q4 (≥20.1) | 117 | 28.8 | 152 | 25.0 | 1.42 | 0.99, 2.03 | 1.42 | 0.98, 2.05 |
| Ptrend | 0.06 | 0.06 | ||||||
| Per 10 g/1,000 kcal‡ | 1.23 | 1.05, 1.43 | 1.23 | 1.05, 1.43 | ||||
| Sucrose | ||||||||
| Q1 (≤ 14.0) | 78 | 19.2 | 153 | 25.1 | 1.00 | Ref | 1.00 | Ref |
| Q2 (14.1-19.9) | 116 | 28.6 | 152 | 25.0 | 1.53 | 1.05, 2.22 | 1.51 | 1.03, 2.21 |
| Q3 (20.0-27.5) | 105 | 25.9 | 152 | 25.0 | 1.38 | 0.94, 2.02 | 1.33 | 0.90, 1.96 |
| Q4 (≥27.6) | 107 | 26.4 | 152 | 25.0 | 1.37 | 0.94, 1.99 | 1.39 | 0.95, 2.04 |
| Ptrend | 0.28 | 0.24 | ||||||
| Per 10 g/1,000 kcal‡ | 1.07 | 0.96, 1.19 | 1.07 | 0.96, 1.19 | ||||
| Added sugars, tsp/1,000kcal | ||||||||
| Q1 (≤ 5.3) | 85 | 20.9 | 153 | 25.1 | 1.00 | Ref | 1.00 | Ref |
| Q2 (5.4-7.7) | 92 | 22.7 | 152 | 25.0 | 1.14 | 0.78, 1.66 | 1.12 | 0.76, 1.65 |
| Q3 (7.8-10.9) | 118 | 29.1 | 153 | 25.1 | 1.42 | 0.98, 2.05 | 1.39 | 0.95, 2.04 |
| Q4 (≥11.0) | 111 | 27.3 | 151 | 24.8 | 1.40 | 0.97, 2.03 | 1.33 | 0.90, 1.98 |
| Ptrend | 0.06 | 0.13 | ||||||
| Per 6 tsp/1,000 kcal‡ | 1.23 | 1.03, 1.46 | 1.20 | 0.99, 1.44 | ||||
| Starch, g/1,000kcal | ||||||||
| Q1 (≤ 42.7) | 122 | 30.1 | 156 | 25.6 | 1.00 | Ref | 1.00 | Ref |
| Q2 (42.8-48.8) | 82 | 20.2 | 150 | 24.6 | 0.75 | 0.52, 1.08 | 0.75 | 0.52, 1.09 |
| Q3 (48.9-54.9) | 105 | 25.9 | 151 | 24.8 | 0.89 | 0.63, 1.27 | 0.86 | 0.60, 1.23 |
| Q4 (≥55.0) | 97 | 23.9 | 152 | 25.0 | 0.83 | 0.58, 1.18 | 0.84 | 0.59, 1.21 |
| Ptrend | 0.39 | 0.41 | ||||||
| Per 10 g/1,000 kcal‡ | 0.96 | 0.85, 1.09 | 0.97 | 0.85, 1.09 | ||||
| Total fiber, g/1,000kcal | ||||||||
| Q1 (≤ 6.5) | 117 | 28.8 | 163 | 26.8 | 1.00 | Ref | 1.00 | Ref |
| Q2 (6.6-8.3) | 104 | 25.6 | 142 | 23.3 | 0.92 | 0.64, 1.32 | 0.85 | 0.58, 1.22 |
| Q3 (8.4-10.8) | 86 | 21.2 | 156 | 25.6 | 0.69 | 0.46, 1.01 | 0.64 | 0.43, 0.94 |
| Q4 (≥10.9) | 99 | 24.4 | 148 | 24.3 | 0.88 | 0.60, 1.30 | 0.79 | 0.53, 1.17 |
| Ptrend | 0.51 | 0.27 | ||||||
| Per 4 g/1,000 kcal‡ | 0.92 | 0.79, 1.06 | 0.88 | 0.76, 1.03 | ||||
| Glycemic load, units/1,000kcal | ||||||||
| Q1 (≤ 50.8) | 83 | 20.4 | 155 | 25.5 | 1.00 | Ref | 1.00 | Ref |
| Q2 (50.9-57.9) | 90 | 22.2 | 152 | 25.0 | 1.10 | 0.75, 1.60 | 1.16 | 0.79, 1.71 |
| Q3 (58.0-64.9) | 125 | 30.8 | 150 | 24.6 | 1.53 | 1.07, 2.21 | 1.57 | 1.09, 2.28 |
| Q4 (≥65.0) | 108 | 26.6 | 152 | 25.0 | 1.31 | 0.91, 1.90 | 1.35 | 0.93, 1.97 |
| Ptrend | 0.06 | 0.05 | ||||||
| Per 10 units/1,000 kcal‡ | 1.17 | 1.04, 1.32 | 1.18 | 1.04, 1.33 | ||||
| Glycemic index, units | ||||||||
| Q1 (≤ 49.9) | 96 | 23.7 | 155 | 25.5 | 1.00 | Ref | 1.00 | Ref |
| Q2 (50.0-52.2) | 108 | 26.6 | 152 | 25.0 | 1.10 | 0.77, 1.58 | 1.17 | 0.81, 1.69 |
| Q3 (52.3-54.8) | 103 | 25.4 | 156 | 25.6 | 0.97 | 0.68, 1.40 | 0.95 | 0.66, 1.38 |
| Q4 (≥54.9) | 99 | 24.4 | 146 | 24.0 | 0.97 | 0.67, 1.40 | 1.03 | 0.70, 1.50 |
| Ptrend | 0.73 | 0.86 | ||||||
| Per 5 units‡ | 0.99 | 0.84, 1.17 | 1.00 | 0.84, 1.18 | ||||
tsp, teaspoon
Model 1 adjusted for age, education, region, and total energy intake.
Model 2 adjusted for age, education, region, total energy intake, parity, oral contraceptive use, menopause status, tubal ligation, and family history of breast/ovarian cancer (first-degree relative). For added sugars, model additional adjusted for vegetable intake. For fiber, model additional adjusted for alcohol consumption.
Increment used in continuous analyses based on the difference between 75th and 25th percentile of the control distribution, rounded to one significant digit.
We found a positive linear association between GL and ovarian cancer risk (OR, 1.18 for each 10 units/1,000 kcal; 95% CI, 1.04-1.33). However, we only observed a significant association when comparing the third quartile vs. the lowest (OR, 1.57; 95% CI, 1.09-2.28) but not for the highest quartile of GL. There was no evidence of an association between GI and ovarian cancer, with ORs near the null and not statistically significant.
Our results were not materially altered with further adjustment for BMI or diabetes. Results for fiber were not altered after adjusting for total or added sugars intake. Estimates for total carbohydrates, total sugars, and GL were strengthened after adjusting for total fat or saturated fat intake (Supplemental Table 2), although the interpretation should be cautious since this isocaloric model estimates the effect of substituting carbohydrates for the same amount of non-fat sources of energy. Results for added sugars, fiber, or GI remained unchanged.
Results for carbohydrate intake, GL and GI as continuous variables were stratified by diabetes status in addition to interaction tests as the number of women with diabetes was small (Supplementary Table 3). Although interaction tests were not statistically significant, the positive association between carbohydrate intake, total sugars, added sugars, and GL with ovarian cancer risk appeared to be stronger among participants with diabetes. We also evaluated effect modification by menopausal status and BMI. No significant interaction was found. Associations were also evaluated by histologic subtype. Given the small number of non-serous subtypes, they were combined for analysis. The findings did not seem to be different for serous vs. non-serous subtypes of ovarian cancer (data not shown). Further adjusting for smoking did not alter this result.
Discussion
In this first population-based study of carbohydrate intake and ovarian cancer risk in African-American women, we observed that high carbohydrate and sugars intakes were associated with a greater risk of ovarian cancer, independent of several relevant non-dietary and dietary factors. There was also a suggestion of a positive association between GL and ovarian cancer risk. The association between carbohydrate intake, sugars (total and added) intakes or GL, and ovarian cancer appeared to be stronger for women with diabetes, though the interaction tests were not statistically significant.
Total carbohydrate intake is a combination of sugars, starch, and fiber consumption. Our results suggested that the positive association between carbohydrate intake and ovarian cancer risk was primarily driven by sugars intake. In support of our findings, a previous study found higher consumption of bread, pasta, rice and more total sugars intake were associated with an increased risk of ovarian cancer(16). However, other studies reported an inverse association(19), or no association between sugars intake and ovarian cancer risk(13, 15, 17, 18).
The inconsistencies in findings between our study and most of the previous studies, which were mainly conducted in European or European-American women, may be due to differences in consumption of sugars types or glucose metabolism of African Americans. Although the range of carbohydrate and total sugars intake in our study is comparable with those reported in other studies(19), the differences in the intake of sugars subtypes have been noticed comparing African Americans and European Americans. According to the National Health and Nutrition Examination Survey (NHANES) III, African Americans have a higher consumption of fructose compared to non-Hispanic Whites(40). Evidence is accumulating that compared to other sugars, fructose is more involved in the development of insulin resistance(41), a hypothesized mechanism for ovarian cancer(42). Consistently, we found a positive association between fructose consumption and ovarian cancer risk. Furthermore, African Americans are more hyperinsulinemic and insulin resistant compared to European Americans(30), suggesting that they may have a higher ovarian cancer risk for a given amount of sugars intake. Another reason to explain the inconsistent findings may be due to the different energy-adjustment methods. It was suggested that nutrient density method as used in our study, or residual method, may be more powerful than the standard energy-adjustment model employed in most of the previous studies (13, 15, 18) to detect the relative odds when the nutrient variables were categorized(43).
The evidence regarding the association between fiber intake and ovarian cancer risk has been inconsistent. While some studies found no association between fiber intake and the risk of ovarian cancer(10, 14, 21, 44), others found an inverse association(9, 11-13, 20). Two of these studies further examined types of fiber intake and showed that the inverse association was observed only for vegetable fiber but not for fruit or cereal fiber(11, 20). Our data, which observed an inverse association with dietary fiber from vegetable and fruit but not with fiber from grains, supports that the effects of dietary fiber on ovarian cancer may vary depending on the food sources.
Among the few prior studies examining associations of GL, GI with ovarian cancer risk(13, 15, 18, 24, 25), our results are consistent with those of a prospective cohort study and a population-based case-control study which showed positive associations with GL but not with GI(13, 15). The null findings with GI suggested that it may not be as good as GL to reflect the overall glycemic effect of the diet, since GL also takes the amount of carbohydrate intake into consideration in addition to carbohydrate quality as for GI(24).
Potential mechanisms linking carbohydrate-rich foods to ovarian tumor development have been proposed. Long-term consumption of carbohydrate-rich foods can result in a chronic hyperinsulinemia, which can indirectly promote the production of insulin-like growth factor-1 (IGF-1)(7). IGF-1 is recognized to play a critical role in promoting cell proliferation and inhibiting apoptosis(45). Higher circulating concentrations of IGF-1 were found in several cancer types such as prostate cancer and breast cancer(46), but the evidence for ovarian cancer is inconsistent(47-49). Insulin and IGF-1 may also promote tumorigenesis through stimulating the production of sex hormones, especially androgens(50), which has been implicated in the pathogenesis of ovarian cancer(51). In addition, the acute glucose fluctuations were found to evoke oxidative stress(52), with subsequent oxidative DNA damage(53), which was suggested to be involved in cancer development(53).
Our results of a stronger association between sugars, GL and ovarian cancer among diabetic participants are biologically plausible, although we had limited power to detect a significant statistical interaction. Type II diabetic patients may suffer from long-term higher compensatory rise in insulin(8), which in turn may increase cancer risk or growth via elevated IGFs(7). Additionally, the cross-talk between the advanced glycation end products (AGE) and receptor for AGE (RAGE) system and oxidative stress is suggested to further increase the risk for cancers in diabetic patients(54). While our results can be chance findings and need to be replicated, given the high prevalence of diabetes among African Americans and that ovarian cancer patients with diabetes exhibit poorer survival(55), primary dietary interventions may be especially important for this vulnerable population.
A number of limitations of the current study should be considered. First, residual confounding is possible, even with adjusting for a wide array of covariates. Second, there is a concern that undetected ovarian cancer may influence dietary choices in the year before diagnosis, leading to an issue of reverse causation. However, this is unlikely for ovarian cancer considering the median prediagnostic symptom duration for invasive cases is 4 months(56). In addition, we found no difference in any dietary variables under study between cases at early stages vs. advanced stages, which argues against undetected disease influencing dietary choices. Third, recall bias is always possible in case-control studies, but the largely unknown relation between sugary foods and ovarian cancer and, as a result, lack of awareness of this link in this population should minimize this problem. Fourth, self-reported carbohydrate intake may be subject to under-reporting(57), and may limit our confidence to estimate the absolute amount of intake. However, FFQs have been shown to be a useful tool to rank individuals reliably based on their nutrient intakes, as in the current study(38). FFQ measured dietary GI and GL have also been shown to be valid and reliable tools to investigate their relationships with disease risks(58, 59). Furthermore, participation rates in population-based epidemiologic studies is declining but, while this is of concern, we found the distribution of main risk factors among AACES ovarian cancer cases and controls were similar to other studies among African Americans(60). Reduced response rates do not necessarily compromise the internal validity of the study, since representative samples could still be achieved with proper study designs(61).
Major strengths of this study include the largest sample for this understudied population and carefully collected information which provides an unprecedented opportunity for studying the modifiable risk factors in this minority population.
In conclusion, the current study supports a detrimental role of a carbohydrate-rich diet in ovarian cancer. Considering the poorer survival among African-American ovarian cancer patients and no effective screening tool for ovarian cancer, prevention is especially important, particularly through dietary modification, which is relatively low cost and low risk compared to medical treatments. In addition, our findings suggest even greater risk from high carbohydrate intake among diabetics, although no significant statistical interaction was identified. As diabetes is more common among African-American women(62), this finding may have important implications for ovarian cancer prevention in this population.
Supplementary Material
Supplemental Table S1. Top 5 food sources that contribute to carbohydrates, sugars, or glycemic load by cases and controls in AACES*
Supplemental Table S2. Multivariable-adjusted association between daily dietary carbohydrate intake and ovarian cancer risk in AACES
Supplemental Table S3. Association between dietary carbohydrate intake in continuous measure and ovarian cancer risk by diabetic status in AACES 2010-2014*†
Acknowledgments
We would like to acknowledge the AACES interviewers, Christine Bard, LaTonda Briggs, Whitney Franz (North Carolina) and Robin Gold (Detroit). We also acknowledge the individuals responsible for facilitating case ascertainment across the ten sites including: Jennifer Burczyk-Brown (Alabama); Rana Bayakly and Vicki Bennett (Georgia); the Louisiana Tumor Registry; Lisa Paddock and Manisha Narang (New Jersey); Diana Slone, Yingli Wolinsky, Steven Waggoner, Anne Heugel, Nancy Fusco, Kelly Ferguson, Peter Rose, Deb Strater, Taryn Ferber, Donna White, Lynn Borzi, Eric Jenison, Nairmeen Haller, Debbie Thomas, Vivian von Gruenigen, Michele McCarroll, Joyce Neading, John Geisler, Stephanie Smiddy, David Cohn, Michele Vaughan, Luis Vaccarello, Elayna Freese, James Pavelka, Pam Plummer, William Nahhas, Ellen Cato, John Moroney, Mark Wysong, Tonia Combs, Marci Bowling, Brandon Fletcher, Yingli Wolinsky (Ohio); Susan Bolick, Donna Acosta, Catherine Flanagan (South Carolina); Martin Whiteside (Tennessee) and Georgina Armstrong and the Texas Registry, Cancer Epidemiology and Surveillance Branch, Department of State Health Services.
Financial support: The AACES study was funded by NCI (R01CA142081). Additional support was provided by Metropolitan Detroit Cancer Surveillance System (MDCSS) with federal funds from the National Cancer Institute, National Institute of Health, Dept. of Health and Human Services, under Contract No. HHSN261201000028C and the Epidemiology Research Core, supported in part by NCI Center Grant (P30CA22453) to the Karmanos Cancer Institute, Wayne State University School of Medicine and NCI Center Grant (P30CA072720) to the Rutgers Cancer Institute of New Jersey.
The funders had no role in the design, analysis or writing of this article.
Footnotes
Conflict of interest: None.
References
- 1.American Cancer Society. Cancer facts & figures 2015. [accessed April 2015];2015 Internet: http://www.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2015/
- 2.Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108. doi: 10.3322/caac.21262. [DOI] [PubMed] [Google Scholar]
- 3.Berek JS, Friedlander ML, Bast RC., Jr . Ovarian cancer. In: Kufe DW, Iii EF, Holland JF, Weichselbaum RR, Pollock RE, Bast RC Jr, Hong WK, Hait WN, editors. Holland-frei cancer medicine. 8th. Shelton, CT: People's Medical Publishing House-USA; 2010. pp. 1344–75. [Google Scholar]
- 4.Goff BA, Mandel L, Muntz HG, et al. Ovarian carcinoma diagnosis. Cancer. 2000;89:2068–2075. doi: 10.1002/1097-0142(20001115)89:10<2068::aid-cncr6>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
- 5.Chornokur G, Amankwah EK, Schildkraut JM, et al. Global ovarian cancer health disparities. Gynecol Oncol. 2013;129:258–264. doi: 10.1016/j.ygyno.2012.12.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.World Cancer Research Fund / American Institute for Cancer Research. Continuous Update Project Report. Food, Nutrition, Physical Activity, and the Prevention of Ovarian Cancer 2014 2014 [Google Scholar]
- 7.Cohen DH, LeRoith D. Obesity, type 2 diabetes, and cancer: the insulin and IGF connection. Endocr Relat Cancer. 2012;19:F27–45. doi: 10.1530/ERC-11-0374. [DOI] [PubMed] [Google Scholar]
- 8.Kaaks R, Lukanova A. Energy balance and cancer: the role of insulin and insulin-like growth factor-I. Proc Nutr Soc. 2001;60:91–106. doi: 10.1079/pns200070. [DOI] [PubMed] [Google Scholar]
- 9.Tzonou a, Hsieh CC, Polychronopoulou a, et al. Diet and ovarian cancer: a case-control study in Greece. Int J Cancer. 1993;55:411–414. doi: 10.1002/ijc.2910550314. [DOI] [PubMed] [Google Scholar]
- 10.Shu XO, Gao YT, Yuan JM, et al. Dietary factors and epithelial ovarian cancer. Br J Cancer. 1989;59:92–96. doi: 10.1038/bjc.1989.18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Risch Ha, Jain M, Marrett LD, et al. Dietary fat intake and risk of epithelial ovarian cancer. J Natl Cancer Inst. 1994;86:1409–1415. doi: 10.1093/jnci/86.18.1409. [DOI] [PubMed] [Google Scholar]
- 12.McCann SE, Freudenheim JL, Marshall JR, et al. Risk of human ovarian cancer is related to dietary intake of selected nutrients, phytochemicals and food groups. J Nutr. 2003;133:1937–1942. doi: 10.1093/jn/133.6.1937. [DOI] [PubMed] [Google Scholar]
- 13.Nagle CM, Kolahdooz F, Ibiebele TI, et al. Carbohydrate intake, glycemic load, glycemic index, and risk of ovarian cancer. Ann Oncol. 2011;22:1332–1338. doi: 10.1093/annonc/mdq595. [DOI] [PubMed] [Google Scholar]
- 14.Kushi LH, Mink PJ, Folsom AR, et al. Prospective study of diet and ovarian cancer. Am J Epidemiol. 1999;149:21–31. doi: 10.1093/oxfordjournals.aje.a009723. [DOI] [PubMed] [Google Scholar]
- 15.Silvera SN, Jain M, Howe GR, et al. Glycaemic index, glycaemic load and ovarian cancer risk: a prospective cohort study. Public Health Nutr. 2007;10:1076–1081. doi: 10.1017/S1368980007696360. [DOI] [PubMed] [Google Scholar]
- 16.Bosetti C, Negri E. Diet and ovarian cancer risk: A case-control study in Italy. Int J Cancer. 2001;915:911–915. doi: 10.1002/ijc.1422. [DOI] [PubMed] [Google Scholar]
- 17.Bidoli E, La Vecchia C, Montella M, et al. Nutrient intake and ovarian cancer: An Italian case-control study. Cancer Causes Control. 2002;13:255–261. doi: 10.1023/a:1015047625060. [DOI] [PubMed] [Google Scholar]
- 18.King MG, Olson SH, Paddock L, et al. Sugary food and beverage consumption and epithelial ovarian cancer risk: a population-based case-control study. BMC cancer. 2013;13:94. doi: 10.1186/1471-2407-13-94. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Tasevska N, Jiao L, Cross AJ, et al. Sugars in diet and risk of cancer in the NIH-AARP Diet and Health Study. Int J Cancer. 2012;130:159–169. doi: 10.1002/ijc.25990. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Pelucchi C, La Vecchia C, Chatenoud L, et al. Dietary fibres and ovarian cancer risk. Eur J Cancer. 2001;37:2235–2239. doi: 10.1016/s0959-8049(01)00291-x. [DOI] [PubMed] [Google Scholar]
- 21.Silvera SN, Jain M, Howe GR, et al. Dietary fiber intake and ovarian cancer risk: a prospective cohort study. Cancer Causes Control. 2007;18:335–341. doi: 10.1007/s10552-006-0107-6. [DOI] [PubMed] [Google Scholar]
- 22.Wolever TM, Jenkins DJ, Jenkins AL, et al. The glycemic index: methodology and clinical implications. The American journal of clinical nutrition. 1991;54:846–854. doi: 10.1093/ajcn/54.5.846. [DOI] [PubMed] [Google Scholar]
- 23.Salmeron J, Manson JE, Stampfer MJ, et al. Dietary fiber, glycemic load, and risk of non—insulin-dependent diabetes mellitus in women. JAMA. 1997;277:472–477. doi: 10.1001/jama.1997.03540300040031. [DOI] [PubMed] [Google Scholar]
- 24.George SM, Mayne ST, Leitzmann MF, et al. Dietary glycemic index, glycemic load, and risk of cancer: a prospective cohort study. Am J Epidemiol. 2009;169:462–472. doi: 10.1093/aje/kwn347. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Augustin L, Polesel J. Dietary glycemic index, glycemic load and ovarian cancer risk: a case–control study in Italy. Ann Oncol. 2003;14:78–84. doi: 10.1093/annonc/dkg022. [DOI] [PubMed] [Google Scholar]
- 26.U.S. Department of Agriculture, Agricultural Research Service, Beltsville Human Nutrition Research Center, Food Surveys Research Group (Beltsville, MD) and U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics (Hyattsville, MD) What we eat in America, NHANES 2011-2012. [accessed May 2015]; Internet: http://www.ars.usda.gov/Services/docs.htm?docid=18349.
- 27.Welsh JA, Sharma AJ, Grellinger L, et al. Consumption of added sugars is decreasing in the United States. Am J Clin Nutr. 2011;94:726–734. doi: 10.3945/ajcn.111.018366. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Lovejoy JC, Champagne CM, Smith SR, et al. Ethnic differences in dietary intakes, physical activity, and energy expenditure in middle-aged, premenopausal women: the Healthy Transitions Study. Am J Clin Nutr. 2001;74:90–95. doi: 10.1093/ajcn/74.1.90. [DOI] [PubMed] [Google Scholar]
- 29.Das SK, Sharma NK, Zhang B. Integrative network analysis reveals different pathophysiological mechanisms of insulin resistance among Caucasians and African Americans. BMC Med Genomics. 2015;8:4. doi: 10.1186/s12920-015-0078-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Haffner SM, Ralph DA, Saad MF, et al. Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic Whites: The Insulin Resistance Atherosclerosis Study. Diabetes. 1996;45:742–748. doi: 10.2337/diab.45.6.742. [DOI] [PubMed] [Google Scholar]
- 31.Pearce CL, Templeman C, Rossing MA, et al. Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case–control studies. Lancet Oncol. 2012;13:385–394. doi: 10.1016/S1470-2045(11)70404-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Yang HP, Trabert B, Murphy MA, et al. Ovarian cancer risk factors by histologic subtypes in the NIH-AARP diet and health study. Int J Cancer. 2012;131:938–948. doi: 10.1002/ijc.26469. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Schildkraut JM, Alberg AJ, Bandera EV, et al. A multi-center population-based case-control study of ovarian cancer in African-American women: the African American Cancer Epidemiology Study (AACES) BMC cancer. 2014;14:688. doi: 10.1186/1471-2407-14-688. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Boucher B, Cotterchio M, Kreiger N, et al. Validity and reliability of the Block98 food-frequency questionnaire in a sample of Canadian women. Public Health Nutr. 2006;9:84–93. doi: 10.1079/phn2005763. [DOI] [PubMed] [Google Scholar]
- 35.Mares-Perlman JA, Klein B, Klein R, et al. A diet history questionnaire ranks nutrient intakes in middle-aged and older men and women similarly to multiple food records. J Nutr. 1993;123:489–501. doi: 10.1093/jn/123.3.489. [DOI] [PubMed] [Google Scholar]
- 36.Foster-Powell K, Holt SH, Brand-Miller JC. International table of glycemic index and glycemic load values: 2002. Am J Clin Nutr. 2002;76:5–56. doi: 10.1093/ajcn/76.1.5. [DOI] [PubMed] [Google Scholar]
- 37.Willett WC, Howe GR, Kushi LH. Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr. 1997;65:1220S–1228S. doi: 10.1093/ajcn/65.4.1220S. [DOI] [PubMed] [Google Scholar]
- 38.Willett W. Nutritional epidemiology. 3rd. Oxford University Press; 2012. [Google Scholar]
- 39.Collaborative Group on Epidemiological Studies of Ovarian Cancer. Ovarian cancer and smoking: individual participant meta-analysis including 28 114 women with ovarian cancer from 51 epidemiological studies. The Lancet Oncology. 2012;13:946–956. doi: 10.1016/S1470-2045(12)70322-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Vos MB, Kimmons JE, Gillespie C, et al. Dietary fructose consumption among US children and adults: the Third National Health and Nutrition Examination Survey. Medscape J Med. 2008;10:160. [PMC free article] [PubMed] [Google Scholar]
- 41.Johnson RJ, Perez-Pozo SE, Sautin YY, et al. Hypothesis: could excessive fructose intake and uric acid cause type 2 diabetes? Endocr Rev. 2009;30:96–116. doi: 10.1210/er.2008-0033. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Arcidiacono B, Iiritano S, Nocera A, et al. Insulin resistance and cancer risk: an overview of the pathogenetic mechanisms. Exp Diabetes Res. 2012;2012 doi: 10.1155/2012/789174. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Brown CC, Kipnis V, Freedman LS, et al. Energy Adjustment Methods for Nutritional Epidemiology: The Effect of Categorization. Am J Epidemiol. 1994;139:323–338. doi: 10.1093/oxfordjournals.aje.a117000. [DOI] [PubMed] [Google Scholar]
- 44.Salazar-Martinez E, Lazcano-Ponce EC, Gonzalez Lira-Lira G, et al. Nutritional determinants of epithelial ovarian cancer risk: a case-control study in Mexico. Oncology. 2002;63:151–157. doi: 10.1159/000063814. [DOI] [PubMed] [Google Scholar]
- 45.Yu H, Rohan T. Role of the Insulin-Like Growth Factor Family in Cancer Development and Progression. J Natl Cancer Inst. 2000;92:1472–1489. doi: 10.1093/jnci/92.18.1472. [DOI] [PubMed] [Google Scholar]
- 46.Renehan AG, Zwahlen M, Minder C, et al. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet. 2004;363:1346–1353. doi: 10.1016/S0140-6736(04)16044-3. [DOI] [PubMed] [Google Scholar]
- 47.Ose J, Fortner RT, Schock H, et al. Insulin-like growth factor I and risk of epithelial invasive ovarian cancer by tumour characteristics: results from the EPIC cohort. Br J Cancer. 2015;112:162–166. doi: 10.1038/bjc.2014.566. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Lukanova A, Lundin E, Toniolo P, et al. Circulating levels of insulin-like growth factor-I and risk of ovarian cancer. Int J Cancer. 2002;101:549–554. doi: 10.1002/ijc.10613. [DOI] [PubMed] [Google Scholar]
- 49.Peeters PH, Lukanova A, Allen N, et al. Serum IGF-I, its major binding protein (IGFBP-3) and epithelial ovarian cancer risk: the European Prospective Investigation into Cancer and Nutrition (EPIC) Endocr Relat Cancer. 2007;14:81–90. doi: 10.1677/erc.1.01264. [DOI] [PubMed] [Google Scholar]
- 50.Cara J. Insulin-like growth factors, insulin-like growth factor binding proteins and ovarian androgen production. Horm Res Paediatr. 1994;42:49–54. doi: 10.1159/000184145. [DOI] [PubMed] [Google Scholar]
- 51.Risch HA. Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J Natl Cancer Inst. 1998;90:1774–1786. doi: 10.1093/jnci/90.23.1774. [DOI] [PubMed] [Google Scholar]
- 52.Monnier L, Mas E, Ginet C, et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA. 2006;295:1681–1687. doi: 10.1001/jama.295.14.1681. [DOI] [PubMed] [Google Scholar]
- 53.Kidane D, Chae WJ, Czochor J, et al. Interplay between DNA repair and inflammation, and the link to cancer. Crit Rev Biochem Mol Biol. 2014;49:116–139. doi: 10.3109/10409238.2013.875514. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Abe R, Yamagishi S. AGE-RAGE system and carcinogenesis. Curr Pharm Des. 2008;14:940–945. doi: 10.2174/138161208784139765. [DOI] [PubMed] [Google Scholar]
- 55.Bakhru A, Buckanovich RJ, Griggs JJ. The impact of diabetes on survival in women with ovarian cancer. Gynecol Oncol. 2011;121:106–111. doi: 10.1016/j.ygyno.2010.12.329. [DOI] [PubMed] [Google Scholar]
- 56.Vine MF, Ness RB, Calingaert B, et al. Types and duration of symptoms prior to diagnosis of invasive or borderline ovarian tumor. Gynecol Oncol. 2001;83:466–471. doi: 10.1006/gyno.2001.6411. [DOI] [PubMed] [Google Scholar]
- 57.Poppitt SD, Swann D, Black AE, et al. Assessment of selective under-reporting of food intake by both obese and non-obese women in a metabolic facility. Int J Obes Relat Metab Disord. 1998;22:303–311. doi: 10.1038/sj.ijo.0800584. [DOI] [PubMed] [Google Scholar]
- 58.Du H, van der ADL, van Bakel MM, et al. Reproducibility and relative validity of dietary glycaemic index and glycaemic load assessed by the food-frequency questionnaire used in the Dutch cohorts of the European Prospective Investigation into Cancer and Nutrition. Br J Nutr. 2009;102:601–604. doi: 10.1017/S0007114508207269. [DOI] [PubMed] [Google Scholar]
- 59.Murakami K, Sasaki S, Takahashi Y, et al. Reproducibility and relative validity of dietary glycaemic index and load assessed with a self-administered diet-history questionnaire in Japanese adults. Br J Nutr. 2008;99:639–648. doi: 10.1017/S0007114507812086. [DOI] [PubMed] [Google Scholar]
- 60.Moorman PG, Palmieri RT, Akushevich L, et al. Ovarian cancer risk factors in African-American and white women. Am J Epidemiol. 2009;170:598–606. doi: 10.1093/aje/kwp176. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Nelson DE, Powell-Griner E, Town M, et al. A comparison of national estimates from the National Health Interview Survey and the Behavioral Risk Factor Surveillance System. Am J Public Health. 2003;93:1335–1341. doi: 10.2105/ajph.93.8.1335. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Centers for Disease Control and Prevention. National Diabetes Statistics Report: Estimates of Diabetes and Its Burden in the United States, 2014. Atlanta, GA: US Department of Health and Human Services; 2014. [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Supplemental Table S1. Top 5 food sources that contribute to carbohydrates, sugars, or glycemic load by cases and controls in AACES*
Supplemental Table S2. Multivariable-adjusted association between daily dietary carbohydrate intake and ovarian cancer risk in AACES
Supplemental Table S3. Association between dietary carbohydrate intake in continuous measure and ovarian cancer risk by diabetic status in AACES 2010-2014*†
